X0306 4 2017-05-17 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189727 BURCAR ALISON D 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President and Gen'l Mgr. Common Stock 2017-05-17 4 X 0 1042 43.62 A 3727 D Common Stock 2017-05-17 4 X 0 14649 61.76 A 18376 D Common Stock 2017-05-17 4 S 0 17510 160.6956 D 866 D Common Stock 2017-05-17 4 S 0 200 161.4 D 666 D Common Stock 2017-05-17 4 S 0 141 162.35 D 525 D Common Stock 2017-05-17 4 S 0 432 160.8963 D 93 D Common Stock 2017-05-17 4 S 0 7 162.35 D 86 D Common Stock 2017-05-17 4 X 0 2160 46.53 A 2246 D Non-Qualified Stock Option (right to buy) 43.62 2017-05-17 4 X 0 1042 43.62 D 2021-07-20 Common Stock 1042 0 D Non-Qualified Stock Option (right to buy) 46.53 2017-05-17 4 X 0 2160 46.53 D 2022-02-01 Common Stock 2160 0 D Non-Qualified Stock Option (right to buy) 61.76 2017-05-17 4 X 0 14649 61.76 D 2023-02-06 Common Stock 14649 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.175 to $161.150, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.30 to $161.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.70 to $161.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire, Attorney-in-fact For: Alison D. Burcar 2017-05-18